Active Ingredient: FOSTAMATINIB DISODIUM
Proprietary Name: TAVALISSE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209299
Product Number: 002
Approval Date: Apr 17, 2018
Applicant Holder Full Name: RIGEL PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
